Cv Sciences, Inc. CVSI
We take great care to ensure that the data presented and summarized in this overview for CV Sciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CVSI
View allLatest Institutional Activity in CVSI
Top Purchases
Top Sells
About CVSI
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Insider Transactions at CVSI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2021
|
Joseph C Md Maroon Director |
BUY
Open market or private purchase
|
Direct |
50,000
+5.94%
|
$0
$0.38 P/Share
|
|
Jan 15
2021
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
16,600
-0.91%
|
$0
$0.66 P/Share
|
|
Jan 14
2021
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-5.18%
|
$0
$0.63 P/Share
|
|
Jan 13
2021
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-4.93%
|
$0
$0.61 P/Share
|
|
Jan 07
2021
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,140
-3.57%
|
$0
$0.57 P/Share
|
|
Jan 06
2021
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,000
-3.44%
|
$0
$0.56 P/Share
|
|
Dec 02
2020
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
42,800
-1.93%
|
$0
$0.61 P/Share
|
|
Dec 01
2020
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
57,400
-2.52%
|
$0
$0.61 P/Share
|
|
Nov 30
2020
|
Michael Joseph Mona Jr > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
400,000
-14.93%
|
$0
$0.59 P/Share
|